← All diseases
Brain and nervous system
Multiple system atrophy (MSA)
Would you like to receive a message when there is new research about Multiple System Atrophy (MSA)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was studied — and you'll receive a message as soon as there is new research about Multiple System Atrophy (MSA). View what Premium costs.
Publications and studies (1558)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Contributions of seeding amplification assays to the diagnosis of synucleinopathies]. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple system atrophy: integrating clinical phenotypes and multimodal biomarkers for early diagnosis. (2026/05/29) ♡
- Safety, Feasibility, and Efficacy of Immersive Virtual Reality Training With a Body Weight Support System for Patients With Extrapyramidal Disorders: A Pilot Case Series Study. (2026/05/21) ♡
- Periodic alternating nystagmus as a diagnostic clue in MRI-negative Wernicke encephalopathy mimicking multiple system atrophy: a case with complex heterogeneous dizziness. (2026/05/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neurofilament light chain as a diagnostic and prognostic biomarker in atypical parkinsonisms: current evidence, new data, challenges, and future directions. (2026/05/01) ♡
- The influence of vascular risk factors and aging on choroid plexus enlargement. (2026/05/01) ♡
- Mortality in agriculture workers: a case-control study in Italy. (2026/05/01) ♡
- ISPAD, bridging clinical expertise and AI for autoimmune-related pernicious anemia diagnosis. (2026/04/28) ♡
- Subtypes and predictors of mild cognitive impairment in patients with multiple system atrophy. (2026/04/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The HPA axis and kynurenine pathway: exploring the role of stress and neuroinflammation in treatment-resistant depression. (2026/04/01) ♡
- Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder. (2026/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. A wolf in synuclein clothing: Creutzfeldt-Jakob disease disguised as MSA. (2026/04/01) ♡
- Deep Learning-Based Brainstem Segmentation and Multi-Class Classification for Parkinsonian Syndrome. (2026/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The great masquerader: primary vitreoretinal lymphoma presenting as white dot syndrome. (2026/04/01) ♡
- Integration of Volumetric, Iron, and Neuromelanin Magnetic Resonance Imaging Measures Effectively Differentiates Parkinson's Disease from Multiple System Atrophy. (2026/03/01) ♡
- Formation of Condition-Dependent Alpha-Synuclein Fibril Strain in Artificial Cerebrospinal Fluid. (2026/02/01) ♡
- Mild-to-moderate depressive symptoms impact on self-reported outcome measures in clinical trials for neurodegenerative diseases. (2026/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials. (2026/02/01) ♡
- Cardiac autonomic dysfunction in patients with multiple system atrophy and spinocerebellar ataxia: A comparative study and distinctive machine learning model. (2026/02/01) ♡
- Extracellular water-to-total body water ratio predicts phenoconversion in REM sleep behavior disorder: A bioimpedance-based cohort study. (2026/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Percutaneous endoscopic gastrostomy in atypical parkinsonian syndromes: survival and aspiration outcomes from a retrospective international cohort. (2026/01/30) ♡
- The RNA exosome maintains cellular RNA homeostasis by controlling transcript abundance in the brain. (2026/01/27) ♡
- Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility study. (2026/01/15) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial. (2026/01/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Autonomic dysfunction in multiple system atrophy treated with Sun's scalp acupuncture combined with yinyang needling therapy: a case report]. (2026/01/12) ♡
- Characteristics of dysarthria in patients with spinocerebellar degeneration and multiple system atrophy: a cross-sectional and longitudinal study using the Frenchay Dysarthria Assessment Second Edition (FDA-2). (2026/01/07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Xsens motion analysis and virtual reality-based rehabilitation in a national-level badminton player following MPFL reinjury leading to postoperative patellar fracture. (2026/01/02) ♡
- Genomic Characterization of an Emergent Cross-Border Recombinant Duck Plague Virus With High Pathogenicity and Reduced Vaccine Efficacy in Guangxi, China. (2026/01/01) ♡
- Exidavnemab binds to aggregated α-synuclein in human brains affected by α-synucleinopathies. (2026/01/01) ♡
- Ocular motor dysfunction in patients with multiple system atrophy and Parkinson's disease. (2026/01/01) ♡
- Interpeduncular Angle: A Possible Marker to Differentiate Atypical Parkinsonism from Idiopathic Parkinson's Disease. (2026/01/01) ♡
- ERBB4 colocalizes with phosphorylated tau aggregates in multiple tauopathies. (2026/01/01) ♡
- A unique microglia subset associated with aggressive α-synucleinopathy uncovered in a rapidly progressive multiple system atrophy cerebellar type model. (2026/01/01) ♡
- Free-water imaging reveals cholinergic pathway damage in multiple system atrophy. (2026/01/01) ♡
- Cortical and subcortical gray matter alterations link cerebral small vessel disease burden to motor slowing: A cross-sectional and longitudinal study. (2026/01/01) ♡
- Skin-derived α-synuclein strains from PD, DLB, and MSA induce distinct intracellular pathology and neurodegeneration. (2026/01/01) ♡
- Methylene blue protects oligodendroglial cell models of multiple systems atrophy against hydrogen peroxide-mediated oxidative stress. (2026/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ocular and Neuro-Ophthalmic Manifestations of Chronic Inflammatory Demyelinating Polyneuropathy. (2026/01/01) ♡
- Linking the cerebellum posterior lobules atrophy to multiple system atrophy cognitive impairment. (2026/01/01) ♡
- Tri-modal assessment reveals early visual pathway degeneration in patients with MSA-C. (2026/01/01) ♡
- Constructed growth charts and nutrition for pontocerebellar hypoplasia type 2A. (2026/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Persisting Transglutaminase 6 Antibodies in Neurological Gluten-Related Disorders. (2026/01/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping (2026-08-11) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA) (2026-08-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study (2026-08-10) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs (2026-08-10) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients (2026-08-07) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (2026-08-07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Laboratory Evaluation of Chronic Autonomic Failure (2026-08-04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA) (2026-08-04) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.